<!doctype html>
<html>
<head>

<meta charset="UTF-8">
<meta name="apple-mobile-web-app-capable" content="yes">
<meta name="viewport" content="width=device-width initial-scale=1, user-scalable=no">
<meta name="apple-mobile-web-app-title" content="BRILINTA - Efficacy or Firstline">
<title>BRILINTA - Efficacy or Firstline</title>
<link rel="stylesheet" type="text/css" href="css/style.css" />


<link rel="stylesheet" href="./css/swiper.min.css">

<style type="text/css">

	/* ==== YOUR CSS HERE ===== */
/*Alistair Added in*/


.container{
	background:url('./img/patient_picture.jpg');
	background-size: 100%;
	background-repeat: no-repeat;
}
.brilOrange
{
	position: absolute;
	margin-top: 390px;
	margin-left: 420px;
	width:400px;
	font-size: 23px;
}
.belowOrangeText
{
	color: white;
	width:270px;
	position: absolute;
	margin-top:420px;
	margin-left:420px;
    font-family: 'HelveNeuLig';
}
.graphImage
{
    background: url('./img/risk_graph.jpg');
    background-size: 100%;
    background-repeat: no-repeat;
    width: 800px;
    height:430px;
    margin-left:50px;
}

/*END*/



</style> 
</head>
<body>
	<section class="container">
 		<div class="slide">
       		<ul class="controls">
                <li data-control="v">V</li>
                <li data-control="p">P</li>
                <li data-control="g">G</li>
                <li data-control="n">N</li>
                <li data-control="pi">PI</li>
                <li data-control="r">R</li>
            </ul>



            <article class="contents">
            	<!--<h1> 
                	<span><i>Give ACS patients their</i></span> 
                	<span>best chance with 12 months Brilinta <sup>*1</sup></span> 
             	</h1>
                <h4>Compared with clopidogrel, ACS patients on BRILINTA showed a<br />
consistent reduction in CV mortality in the overall PLATO study.<sup>1</sup></h4>-->



                <!--===== YOUR ELEMENTS/CONTENTS HERE =======-->
              
 				<!--Alistair Added In-->

 				

                <h1>
                	<span><i>THE RISK OF A SECOND</i></span>
                	<br />
                	<span>EVENT IS VERY REAL</span>
                </h1>

                <div class="mainMenu">
                    <h2 class="brilOrange">Use Brilinta for 12 months</h2>
                    <p class="belowOrangeText">At one year, patients undergoing primary PCI remain at high risk of major cardiac events<sup>1</sup></p>
                </div>
                <div class="graphImage" style="display:none;"></div>
            	 <!--END-->

            </article>
            
           <span class="logo"></span>
           <span class="b-links plato">PLATO</span>
           <span class="b-links wallentin">WALLENTIN</span>
         
   		</div><!-- end .slide -->
        <!--overlay -->
        <aside class="overlay hide"> 
        	<!-- references -->
        	<div class="ref hide">
                <h3>REFERENCE:</h3>
                <ol>
                    <li>Stone GW et al. N Engl J Med 2011; 364:326–355.</li>
                </ol>
            </div>
            <!-- Note -->
            <div class="notes hide">
            	<h3>NOTES</h3>
                The reduction in CV events continued to increase throughout the 12-month study period<sup>1</sup><br />
				ARR = absolute risk reduction<br />
				RRR = relative risk reduction<br />
				NNT = number needed to treat<br />
				† When treated according to the PLATO regimen
            </div>


            <!--Alistair Added In-->

        	<div class="refFirst hide">
                <h3>REFERENCES</h3>
                <ol>
                    <li>Caggegi A, et al. Am J Cardiol 2011: 108:355-9.</li>
                </ol>
            </div>

            <div class="notesFirst hide">
            	<h3>NOTES</h3>
            	Data represent the PCI population in an analysis of 1-year clinical outcomes in patients with ACS undergoing pCI or CABG.
            	<br />
            	Major cardiac events were defined as a composite of death, myocardial infraction, or target lesion revascularisation.
            	<br />
            	Adapted from Caggegi A, et al. Am J Cardiol 2011: 108:355-9.
            </div>
            <!--END-->
           
       	</aside>
	</section>
<script type="text/javascript" src="js/jquery-1.11.0.min.js"></script>
<script type="text/javascript" src="js/touchy.js"></script>
<script type="text/javascript" src="js/script.js"></script>
<script type="text/javascript" src="js/swiper.jquery.min.js"></script>

<script type="text/javascript">
	$( function(){

/*Alistair Added in*/

$(".belowOrangeText").click(function() {
       $(".container").css("background","transparent");
       $(".brilOrange").css("display","none");
       $(".graphImage").css("display","block");
    });


		$(".controls > [data-control=v]").on('tap', function(){

		});
		$(".controls > [data-control=p]").on('tap', function(){

		});
		$(".controls > [data-control=g]").on('tap', function(){

		});
		$(".controls > [data-control=n]").on('tap', function(){
            $(".container").css("background","transparent");
			$('.slide').css("display","none");
			$(".overlay").toggleClass('hide show');
			$(".notesFirst").toggleClass('hide show');
			$('.ref').css("display","none");

		});
		$(".controls > [data-control=pi]").on('tap', function(){


		});
		$(".controls > [data-control=r]").on('tap', function(){
            $(".container").css("background","transparent");
			$('.slide').css("display","none");
			$(".overlay").toggleClass('hide show');
			$(".refFirst").toggleClass('hide show');

		});

		$(".dyspnoeaBox").on('tap', function(){

			alert("dyspnoeaBox Clicked");
		});

		


		/*END*/

		/* ==== YOUR SCRIPT HERE ===== */
		
	});

</script>
</body>
</html>
